REVOLUTION MEDICINES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.25 USD | -0.53% |
|
-7.34% | +29.88% |
| May. 09 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
| May. 08 | Revolution Medicines Q1 Net Loss Narrows | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES, INC. | Other Biotechnology & Medical Research | -0.53% | -7.34% | +29.88% | +48.23% | - | 6.15B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RVMD Stock
- Charts Revolution Medicines, Inc.
- Comparison Chart
